202
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Trend differences over 20 years between two methadone maintenance clinics, one with and one without cannabis legalization

, MD, , MSW, LCADC & , PhD

References

  • NIH Consensus Statement, 17–19 November 1997. Effective Medical Treatment of Opiate Addiction, 15, 6.
  • Fullerton CA, Kim M, Thomas CP, Lyman DR, Montejano LB, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME. Medication-assisted treatment with methadone: Assessing the evidence. Psychiatr Serv. 2014;65(2):146–57. doi:10.1176/appi.ps.201300235.
  • Novick DM, Salsitz EA, Joseph H, Kreek MJ. Methadone medical maintenance: An early 21st-century perspective. J Addict Dis. 2015;34(2–3):226–37. doi:10.1080/10550887.2015.1059225.
  • Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York, NY: Springer-Verlag, 1991.
  • Peles E, Sason A, Schreiber S, Adelson M. Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial. Am J Addict. 2017;26(2):167–75. doi:10.1111/ajad.12508.
  • Adelson M, Linzy S, Peles E. Characteristics and outcome of male and female methadone maintenance patients: MMT in Tel Aviv and Las Vegas. Subst Use Misuse. 2018;53(2):230–8. doi:10.1080/10826084.2017.1298619.
  • Peles E, Linzy S, Kreek M, Adelson M. One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel. J Addict Dis. 2008;27(4):11–25. doi:10.1080/10550880802324382.
  • Hawks RL. Analytical methodology. NIDA Res Monogr. 1986; 73:30–42.
  • Ruadze E, Todadze K. Retention in Georgia opioid substitution therapy program and associated factors. Harm Reduct J. 2016;13(1):35. doi:10.1186/s12954-016-0124-z.
  • Proctor SL, Copeland AL, Kopak AM, Hoffmann NG, Herschman PL, Polukhina N. Predictors of patient retention in methadone maintenance treatment. Psychol Addict Behav. 2015;29(4):906–17. doi:10.1037/adb0000090.
  • Peles E, Schreiber S, Sason A, Adelson M. Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center. Drug Alcohol Depend. 2018; 185:112–9. doi:10.1016/j.drugalcdep.2017.11.034.
  • Official state information about marijuana in Nevada. https://marijuana.nv.gov/.
  • Shams I, Sanger N, Bhatt M, Rosic T, Luo C, Shahid H, Mouravska N, Tam SL, Hillmer A, Chawar C, et al. The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment. BJPsych Open. 2019;5(6):e91. doi:10.1192/bjo.2019.78.
  • Levine AR, Lundahl LH, Ledgerwood DM, Lisieski M, Rhodes GL, Greenwald MK. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. J Subst Abuse Treat. 2015; 54:37–43. doi:10.1016/j.jsat.2015.01.009.
  • Zielinski L, Bhatt M, Sanger N, Plater C, Worster A, Varenbut M, Daiter J, Pare G, Marsh DC, Desai D, et al. Association between cannabis use and methadone maintenance treatment outcomes: An investigation into sex differences. Biol Sex Differ. 2017; 8:8. doi:10.1186/s13293-017-0130-1.
  • McBrien H, Luo C, Sanger N, Zielinski L, Bhatt M, Zhu XM, Marsh DC, Thabane L, Samaan Z. Cannabis use during methadone maintenance treatment for opioid use disorder: A systematic review and meta-analysis. CMAJ Open. 2019;7(4):E665–73. doi:10.9778/cmajo.20190026.
  • Lev-Ran S, Le Strat Y, Imtiaz S, Rehm J, Le Foll B. Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: Results from a large representative sample. Am J Addict. 2013;22(1):7–13. doi:10.1111/j.1521-0391.2013.00321.x.
  • Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis. 2010;29(1):1–14. doi:10.1080/10550880903436010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.